Post-traumatic stress disorder (PTSD) is a serious condition that afflicts millions of individuals in the United States. Its complexity has resulted in physicians struggling to effectively implement and maintain treatment. Emerging studies suggest that ±3,4-Methylenedioxymethamphetamine (MDMA), or “ecstasy”, may prove beneficial in treating PTSD in combination with conventional psychotherapy. By acting on the 5-HT transporter in the brain, MDMA has been found to have positive effects on brain activity; encouraging neuroplasticity through the accumulation of brain-derived neurotrophic factor (BDNF). Integrating psychoactive drugs into polytrauma therapy will broaden our understanding of the components involved in maintaining wellness in the human psyche.
Type (DCMI Terms)
Image; StillImage; Text
Baxter, Ashley A., "±3,4-Methylenedioxymethamphetamine: Treating PTSD in The Modern World: A Groundbreaking Methodology for Spiritual Wellness and Neuroplasticity" (2016). Academic Excellence Showcase Proceedings. 90.